Zusammenfassung
In der Erforschung von Interaktionen zwischen Schmerz und Juckreiz sind in den letzten Jahren erhebliche Fortschritte erzielt worden. Über die bekannte Hemmung von Juckreiz durch schmerzhafte Reize (z. B. kratzen) hinaus wurde durch die Entdeckung von juckreizspezifischen neuronalen Verarbeitungsbahnen eine Grundlage zur Erklärung von opioidinduziertem Juckreiz geschaffen. Während traditionell die mastzelldegranulierende Wirkung von Opioiden als wesentlicher Mechanismus angenommen wurde, ist nunmehr klar, dass Opioide auch auf spinaler Ebene Juckreiz auslösen können: Spinale Juckreizneurone werden tonisch von Hinterhornneuronen des Schmerzsystems gehemmt. Wird diese Hemmung durch Opioide geschwächt, werden die so disinhibierten Juckreizneurone aktiv und vermitteln Juckreiz, ohne dass primäre Afferenzen in der Peripherie erregt werden. Die spinale Auslösung von Juckreiz wird insbesondere bei der Aktivierung von µ-Opioidrezeptoren (μ-OR) beobachtet, während κ-OR überraschenderweise den Juckreiz unterdrücken. Die therapeutischen Implikationen dieser Interaktionen werden im vorliegenden Beitrag ausgeführt.
Abstract
Substantial progress has been achieved in recent years in research on the interaction between pain and pruritus. Over and above the known inhibition of pruritus by painful stimuli (e.g. scratching), a foundation for the explanation of opioid-induced pruritus was laid through the discovery of pruritus-specific neuronal processing channels. Although traditionally the degranulating effect of opioids on mast cells was assumed to be the essential mechanism, it is now clear that opioids can also induce itching at the spinal level. Neurons of the dorsal horn of the pain system inhibit spinal itch neurons. If this inhibition is weakened by opioids, the disinhibited itch neurons become active and mediate itching, without stimulation of the primary afferent peripheral nerves. Spinal triggering of itching is observed in particular by activation of µ-opioid receptors (μ-OR), while κ-OR surprisingly suppress itch. The therapeutic implications of this interaction will be described.
Literatur
Twycross R, Greaves MW, Handwerker H et al (2003) Itch: scratching more than the surface. QJM 96:7–26
Ikoma A, Steinhoff M, Stander S et al (2006) The neurobiology of itch. Nat Rev Neurosci 7:535–547
Katcher J, Walsh D (1999) Opioid-induced itching: morphine sulfate and hydromorphone hydrochloride. J Pain Symptom Manage 17:70–72
Schmelz M, Schmidt R, Bickel A et al (1997) Specific C-receptors for itch in human skin. J Neurosci 17:8003–8008
Andrew D, Craig AD (2001) Spinothalamic lamina 1 neurons selectively sensitive to histamine: a central neural pathway for itch. Nat Neurosci 4:72–77
Stander S, Schmelz M (2006) Chronic itch and pain – similarities and differences. Eur J Pain 10:473–478
Koppert W, Blunk JA, Petersen LJ et al (2001) Different patterns of mast cell activation by muscle relaxants in human skin. Anesthesiology 95:659–667
Blunk JA, Schmelz M, Zeck S et al (2004) Opioid-induced mast cell activation and vascular responses is not mediated by mu-opioid receptors: an in nivo microdialysis study in human skin. Anesth Analg 98:364–370
Nilsson HJ, Levinsson A, Schouenborg J (1997) Cutaneous field stimulation (CFS): a new powerful method to combat itch. Pain 71:49–55
Nagy I, Santha P, Jancso G, Urban L (2004) The role of the vanilloid (capsaicin) receptor (TRPV1) in physiology and pathology. Eur J Pharmacol 500:351–369
Leffler A, Fischer MJ, Rehner D et al (2008) The vanilloid receptor TRPV1 is activated and sensitized by local anesthetics in rodent sensory neurons. J Clin Invest 118:763–776
Vyklicky L, Novakova-Tousova K, Benedikt J et al (2008) Calcium-dependent desensitization of vanilloid receptor TRPV1: a mechanism possibly involved in analgesia induced by topical application of capsaicin. Physiol Res (in press)
Simone DA, Nolano M, Johnson T et al (1998) Intradermal injection of capsaicin in humans produces degeneration and subsequent reinnervation of epidermal nerve fibers: correlation with sensory function. J Neurosci 18:8947–8954
Stander S, Moormann C, Schumacher M et al (2004) Expression of vanilloid receptor subtype 1 in cutaneous sensory nerve fibers, mast cells and epithelial cells of appendage structures. Exp Dermatol 13:129–139
Simone DA, Baumann TK, LaMotte RH (1989) Dose-dependent pain and mechanical hyperalgesia in humans after intradermal injection of capsaicin. Pain 38:99–107
Andrew D, Schmelz M, Ballantyne JC (2003) Itch – mechanisms and mediators. In: Dostrovsky JO, Carr DB, Koltzenburg M (eds) Progress in pain research and management. IASP, Seattle, pp 213–226
Ko MC, Song MS, Edwards T et al (2004) The role of central mu opioid receptors in opioid-induced itch in primates. J Pharmacol Exp Ther 310:169–176
Heyer G, Groene D, Martus P (2002) Efficacy of naltrexone on acetylcholine-induced alloknesis in atopic eczema. Exp Dermatol 11:448–455
Bergasa NV (2008) Pruritus in primary biliary cirrhosis: pathogenesis and therapy. Clin Liver Dis 12:385–406
Jones EA, Neuberger J, Bergasa NV (2002) Opiate antagonist therapy for the pruritus of cholestasis: the avoidance of opioid withdrawal-like reactions. QJM 95:547–552
Thornton JR, Losowsky MS (1988) Opioid peptides and primary biliary cirrhosis. BMJ 297:1501–1504
Marzioni M, Svegliati BG, Alpini G, Benedetti A (2007) Endogenous opioid peptides and chronic liver disease: from bedside to bench. J Hepatol 46:583–586
Maxwell LG, Kaufmann SC, Bitzer S et al (2005) The effects of a small-dose naloxone infusion on opioid-induced side effects and analgesia in children and adolescents treated with intravenous patient-controlled analgesia: a double-blind, prospective, randomized, controlled study. Anesth Analg 100:953–958
Greenwald PW, Provataris J, Coffey J et al (2005) Low-dose naloxone does not improve morphine-induced nausea, vomiting, or pruritus. Am J Emerg Med 23:35–39
Kjellberg F, Tramer MR (2001) Pharmacological control of opioid-induced pruritus: a quantitative systematic review of randomized trials. Eur J Anaesthesiol 18:346–357
Ko MC, Husbands SM (2009) Effects of atypical kappa opioid receptor agonists on intrathecal morphine-induced itch and analgesia in primates. J Pharmacol Exp Ther 328(1):193–200, DOI 10.1124/jpet.108.143925
Lee H, Naughton NN, Woods JH, Ko MC (2007) Effects of butorphanol on morphine-induced itch and analgesia in primates. Anesthesiology 107:478–485
Ko MC, Lee H, Song MS et al (2003) Activation of kappa-opioid receptors inhibits pruritus evoked by subcutaneous or intrathecal administration of morphine in monkeys. J Pharmacol Exp Ther 305:173–179
Delmez JA (2006) Efficacy and safety of a new kappa-opioid receptor agonist for the treatment of uremic pruritus. Nat Clin Pract Nephrol 2:358–359
Yeh YC, Lin TF, Lin FS et al (2008) Combination of opioid agonist and agonist-antagonist: patient-controlled analgesia requirement and adverse events among different-ratio morphine and nalbuphine admixtures for postoperative pain. Br J Anaesth 101:542–548
Dawn AG, Yosipovitch G (2006) Butorphanol for treatment of intractable pruritus. J Am Acad Dermatol 54:527–531
Gunter JB, McAuliffe J, Gregg T et al (2000) Continuous epidural butorphanol relieves pruritus associated with epidural morphine infusions in children. Paediatr Anaesth 10:167–172
Sakai T, Fukano T, Sumikawa K (2001) IV butorphanol reduces analgesia but not pruritus or nausea associated with intrathecal morphine. Can J Anaesth 48:831–832
Horta ML, Morejon LC, da Cruz AW et al (2006) Study of the prophylactic effect of droperidol, alizapride, propofol and promethazine on spinal morphine-induced pruritus. Br J Anaesth 96:796–800
Bonnet MP, Marret E, Josserand J, Mercier FJ (2008) Effect of prophylactic 5-HT3 receptor antagonists on pruritus induced by neuraxial opioids: a quantitative systematic review. Br J Anaesth 101:311–319
Schmidt S, Bethge C, Forster MH, Schafer M (2007) Enhanced postoperative sensitivity to painful pressure stimulation after intraoperative high dose remifentanil in patients without significant surgical site pain. Clin J Pain 23:605–611
Hansen EG, Duedahl TH, Romsing J et al (2005) Intra-operative remifentanil might influence pain levels in the immediate post-operative period after major abdominal surgery. Acta Anaesthesiol Scand 49:1464–1470
Brull SJ, Atanassoff PG, Silverman DG et al (1999) Attenuation of experimental pruritus and mechanically evoked dysesthesiae in an area of cutaneous allodynia. Somatosens Mot Res 16:299–303
Mitra S (2008) Opioid-induced hyperalgesia: pathophysiology and clinical implications. J Opioid Manag 4:123–130
Chu LF, Angst MS, Clark D (2008) Opioid-induced hyperalgesia in humans: molecular mechanisms and clinical considerations. Clin J Pain 24:479–496
Ruan X (2007) Drug-related side effects of long-term intrathecal morphine therapy. Pain Physician 10:357–366
Labuz D, Berger S, Mousa SA et al (2006) Peripheral antinociceptive effects of exogenous and immune cell-derived endomorphins in prolonged inflammatory pain. J Neurosci 26:4350–4358
Bigliardi-Qi M, Sumanovski LT, Buchner S et al (2004) Mu-opiate receptor and beta-endorphin expression in nerve endings and keratinocytes in human skin. Dermatology 209:183–189
Tobin DJ, Kauser S (2005) Beta-endorphin: the forgotten hair follicle melanotropin. J Investig Dermatol Symp Proc 10:212–216
Bigliardi-Qi M, Lipp B, Sumanovski LT et al (2005) Changes of epidermal mu-opiate receptor expression and nerve endings in chronic atopic dermatitis. Dermatology 210:91–99
Chan LS, Robinson N, Xu L (2001) Expression of interleukin-4 in the epidermis of transgenic mice results in a pruritic inflammatory skin disease: an experimental animal model to study atopic dermatitis. J Invest Dermatol 117:977–983
Tredget EE, Yang L, Delehanty M et al (2006) Polarized Th2 cytokine production in patients with hypertrophic scar following thermal injury. J Interferon Cytokine Res 26:179–189
Roy S, Wang J, Charboneau R et al (2005) Morphine induces CD4+ T cell IL-4 expression through an adenylyl cyclase mechanism independent of the protein kinase A pathway. J Immunol 175:6361–6367
Birklein F, Claus D, Riedl B et al (1997) Effects of cutaneous histamine application in patients with sympathetic reflex dystrophy. Muscle Nerve 20:1389–1395
Ikoma A, Fartasch M, Heyer G et al (2004) Painful stimuli evoke itch in patients with chronic pruritus: central sensitization for itch. Neurology 62:212–217
Charuluxananan S, Kyokong O, Somboonviboon W et al (2003) Nalbuphine versus ondansetron for prevention of intrathecal morphine-induced pruritus after cesarean delivery. Anesth Analg 96:1789–1793
Kjellberg F, Tramer MR (2001) Pharmacological control of opioid-induced pruritus: a quantitative systematic review of randomized trials. Eur J Anaesthesiol 18:346–357
Danksagung
Diese Arbeit wurde von der Deutschen Forschungsgemeinschaft (KFO 107) unterstützt.
Interessenkonflikt
Der korrespondierende Autor gibt an, dass kein Interessenkonflikt besteht.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Schmelz, M. Opioidinduzierter Pruritus. Anaesthesist 58, 61–65 (2009). https://doi.org/10.1007/s00101-008-1478-8
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00101-008-1478-8